Table 1. Patient characteristics.
| Characteristic | Telemonitoring (n=96) | Conventional care (n=614) | P value |
|---|---|---|---|
| Sex, n (%) | .01 | ||
| Male | 29 (30) | 274 (45) | |
| Female | 67 (70) | 340 (55) | |
| Age (years), median (IQR) | 53 (41.00‐64.75) | 63 (48.00‐73.00) | <.001 |
| BMI (kg/m2), median (IQR) | 27.98 (24.98‐32.12) | 26.70 (23.50‐30.69) | .12 |
| Smoking status, n (%) | <.001 | ||
| Never | 45 (47) | 190 (31) | |
| Former | 41 (43) | 229 (37) | |
| Current | 10 (10) | 195 (32) | |
| Home status, n (%) | .10 | ||
| Living alone | 17 (18) | 156 (25) | |
| Living together | 79 (82) | 458 (75) | |
| Distance to hospital (km), median (IQR) | 23.05 (10.48‐32.71) | 21.18 (11.25‐30.98) | .60 |
| Place of residence, n (%) | .82 | ||
| Urban | 50 (52) | 312 (51) | |
| Rural | 46 (48) | 302 (49) | |
| Charlson Comorbidity Index (points), median (IQR) | 1.00 (1.00‐2.00) | 1.00 (1.00‐3.00) | .003 |
| COPDa GOLDb, n (%) | .85 | ||
| GOLD I | 1 (5) | 11 (4) | |
| GOLD II | 8 (36) | 106 (43) | |
| GOLD III | 10 (45) | 110 (44) | |
| GOLD IV | 3 (14) | 21 (9) | |
| FEV1 % prec, median (IQR) | 81.50 (55.98‐97.80) | 73.00 (54.00‐90.00) | .07 |
| DTCd, n (%) | .001 | ||
| Asthma | 74 (77) | 366 (60) | |
| COPD | 22 (23) | 248 (40) |
a
COPD: chronic obstructive pulmonary disease.
b
GOLD: Chronic Obstructive Lung Disease staging.
c
FEV1 % pre: predicted forced expiratory volume in 1 second (%).
d
DTC: Diagnosis Treatment Combination.